Anti-ACADM/MCAD antibody [EPR3707] - BSA and Azide free
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal ACADM/MCAD antibody. Carrier free. Suitable for IHC-P, WB and reacts with Human samples.
View Alternative Names
MCAD, Medium chain acyl-CoA dehydrogenase, MCADH, ACADM
- WB
Unknown
Western blot - Anti-ACADM/MCAD antibody [EPR3707] - BSA and Azide free (AB247603)
This data was developed using ab108192, the same antibody clone in a different buffer formulation.
All lanes:
Western blot - Anti-ACADM/MCAD antibody [EPR3707] (<a href='/en-us/products/primary-antibodies/acadm-mcad-antibody-epr3707-ab108192'>ab108192</a>) at 1/1000 dilution
Lane 1:
Human fetal heart tissue lysate at 10 µg
Lane 2:
Human fetal liver tissue lysate at 10 µg
Lane 3:
HeLa cell lysate at 10 µg
Lane 4:
HepG2 cell lysate at 10 µg
Predicted band size: 47 kDa
false
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ACADM/MCAD antibody [EPR3707] - BSA and Azide free (AB247603)
This data was developed using ab108192, the same antibody clone in a different buffer formulation.
Immunohistochemical analysis of ACADM/MCAD in paraffin embedded Human kidney tissue, using ab108192 at a 1/250 dilution.
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ACADM/MCAD antibody [EPR3707] - BSA and Azide free (AB247603)
This data was developed using ab108192, the same antibody clone in a different buffer formulation.
Immunohistochemical analysis of ACADM/MCAD in paraffin embedded Human liver tissue, using ab108192 at a 1/250 dilution.
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
Related conjugates and formulations (1)
-
Anti-ACADM/MCAD antibody [EPR3707]
Reactivity data
You may be interested in:
Why is this recommended?
We recommend this product because it’s often used in the same experiment or related research.
We advise that you always check the datasheet to ensure it fits your experiments, or contact ourtechnical teamfor help.
Product details
ab247603 is the carrier-free version of ab108192.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The enzyme facilitates energy production by breaking down medium-chain fatty acids within mitochondria. MCAD operates as a homotetramer complex where each subunit significantly contributes to its overall function. Such enzymatic activity is important for providing energy particularly when glycogen stores are low. Its efficient operation during fasting states indicates its importance in metabolic homeostasis.
Pathways
Medium-chain acyl-CoA dehydrogenase (MCAD) is integral to the mitochondrial fatty acid beta-oxidation pathway. This pathway is a primary route for fatty acid catabolism ultimately leading to energy production in the form of ATP. MCAD's activity also relates to other fatty acid oxidation enzymes like VLCAD (very-long-chain acyl-CoA dehydrogenase) and SCAD (short-chain acyl-CoA dehydrogenase) which operate on different chain-length fatty acids cooperating to maintain energy balance.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com